... of the National Haemophilia Societies, infected persons and their families receive essential assistance in 15 member countries. It is hoped that this development will sway more and more member countries to consider demands for financial support and provide them with the arguments to succeed. 28 4 2009...

...Alonso Gómez 28 4 2009 Haemostasis 1992;22:305-308 J. Alonso Gomez President of the Spanish and Vice President of the World Federation of Hemophila, Madrid, Spain Negative and Positive Developments during the Last 25 Years Key Words Haemophilia Haemophilia, Spanish Federation...

...R. Mølskov Bech Recombinant factor Vila (rFVIIa) improves haemostasis and eliminates the risk of transmission of blood-borne infection in haemophilia patients with inhibitors, acquired inhibitors to factor VIII or IX or FVII deficiency. rFVIIa has been available on a compassionate use basis since...

...K.M. Rice; G.F. Savidge Data is presented from two compassionate-use clinical trials using recombinant factor VIla (rFVIIa) to treat central nervous system haemorrhage in 18 haemophilia A and B patients with inhibitors, and in 3 patients with FVII deficiency. Prior to rFVIIa treatment 78...

... 18 treatment episodes in 9 patients, age 8-66 years, with haemophilia A and high titre inhibitors cross-reacting with porcine factor VIII. There were no significant adverse effects. Treatment with rFVIIa resulted in a successful outcome in 8 potentially life-threatening (retroperitoneal, subdural...

..., activated prothrombin complex concentrates, and factor VIII of porcine origin, a new recombinant activated factor VII molecule has been evaluated clinically for some years with promising results. The aim of the present paper was to present a series of patients suffering from haemophilia A or B in whom...

...Birgit Hessel; Hans Johnsson; Angela Silveira Plasma from 15 patients with haemophilia A and 4 patients with von Willebrand’s disease (VWD) has been investigated for the presence of antibodies to von Willebrand factor (VWF) using ELISA and immunoblotting systems. All plasma samples were also...

... after the infusion. Seventy-six studies were performed in 55 patients with haemophilia A (37), B (11) or von Willebrand’s disease, type III (7). A sharp rise of soluble fibrin was observed in 2 patients with haemophilia B, indicating that modern factor IX concentrates may still be thrombogenic. A slight...

...Frits R. Rosendaal; Cees Smit; Inge Varekamp; Annette Brocker-Vriends; Theo P.B.M. Suurmeijer; Ernest Briët More than 75% of all Dutch haemophiliacs participated in a mail survey that included a section on acquired immunodeficiency syndrome (AIDS). Although no cases of haemophilia-related AIDS had...

...M.M. Steven; M. Small; L. Pinkerton; R. Madhok; R.D. Sturrock; C.D. Forbes Non-steroidal anti-inflammatory drugs are theoretically contra-indicated in the haemophilias but might be useful for those patients with chronic arthritic pain, as long-term strong analgesics are also undesirable. We carried...

.... Desamino-D-arginine vasopressin Disease, von Willebrand’s Haemophilia Stimulation, endothelial Haemostasis 16: 15-19 (1986) © 1986 S. Kargcr AG. Basel 0301-0147/86/0161-001552.75/0 Endothelial Stimulation by DDAVP in von Willebrand s Disease and Haemophilia l.A. Greer, M. McLaren, J.J.F. Belch, G.D.O...

...C.D. Forbes; S. Renfrew Electroencephalography has been performed in a series of patients with haemophilia and Christmas disease because of the suggestion by other authors of a high incidence of abnormality. In an adult population of haemophiliacs no difference was found in the incidence...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Factor VIII assay Coagulation Haemophilia Haemostasis 7: 1-9 (1978) Some Sources of Error in the One-Stage Assay of Factor VIII Susan E lodi, K atalin Varadi and Susan R...

... antibodies Screening test Haemophilia © 1972 S. Karger AG, Basel 1972 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Factor VIII assay Haemophilia Coagulation Original Articles Haemostasis 3: 94-97 (1974...

... of the Coagulation Defect G. G. N eri Serneri, G. F. G ensini and R. Abbate G ensini Istituto di Clinica Medica Generate (Director: Prof. G .G .N eri Serneri), University of Sassari Medical School, Sassari Key Words. Blood coagulation disorders Blood vessels Haemophilia Abstract. The evaluation...

...C.R.M. Hay The UKHCDO inhibitor guidelines address the diagnosis and management of patients with haemophilia A, haemophilia B and acquired haemophilia. Recommendations are based on best current practice as reflected in the published evidence base. Many current treatment strategies are based...